ALMR Class A Alamar Biosciences, Inc. - Class A common stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$34.36
· of 52w range
· above low
· to high
$18.8552w low
$38.5452w high
your badges
52W Range
$19–$39
Analyst Rating
BUY
Price Target
$35
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ALMR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$34.36
52W Range
$19–$39
ALMR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ALMR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 11.9 | · | · | · | |
| Quick Ratio (MRQ) | 9.7 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
33.8%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 10, 2026 | $-0.22 | $-0.33 | 33.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $30M | |
| Short-term Investments | $0 | |
| Receivables | $13M | |
| Inventory | $38M | |
| Prepaid Expense | $13M | |
| Current Assets | $95M | |
| PP&E (Net) | $10M | |
| Other Non-current Assets | $2M | |
| Total Assets | $140M | |
| Accounts Payable | $6M | |
| Current Liabilities | $24M | |
| Capital Leases | $30M | |
| Other Non-current Liabilities | $599.0K | |
| Total Liabilities | $64M | |
| Common Stock | $1.0K | |
| Paid-in Capital | $10M | |
| Retained Earnings | $-169M | |
| AOCI | $-72.0K | |
| Stockholders' Equity | $-159M | |
| Liabilities + Equity | $140M |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Revenue | $29M | $26M | $16M | $13M | |
| Cost of Revenue | $12M | $12M | $8M | $7M | |
| Gross Profit | $18M | $14M | $9M | $6M | |
| R&D Expense | $14M | $13M | $9M | $8M | |
| SG&A Expense | $17M | $14M | $8M | $7M | |
| Operating Expenses | $31M | $27M | $16M | $15M | |
| Operating Income | $-14M | $-12M | $-8M | $-9M | |
| Interest Income | $2M | $539.0K | $630.0K | $786.0K | |
| Pretax Income | $-13M | $-21M | $-7M | $-8M | |
| Income Tax | $-93.0K | $464.0K | · | · | |
| Net Income | $-13M | $-21M | $-7M | $-8M | |
| EPS (Basic) | $-0.22 | $-1.74 | $-0.62 | $-0.68 | |
| EPS (Diluted) | $-0.22 | $-1.74 | $-0.62 | $-0.68 | |
| Shares (Basic) | 58,665,055 | 12,259,811 | 11,409,556 | 11,258,870 | |
| Shares (Diluted) | 58,665,055 | 12,259,811 | 11,409,556 | 11,258,870 | |
| EBITDA | $-14M | $-12M | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $133M | $65M | · | · | |
| Short-term Investments | $117M | $0 | · | · | |
| Receivables | $20M | $20M | · | · | |
| Inventory | $45M | $40M | · | · | |
| Prepaid Expense | $16M | $17M | · | · | |
| Current Assets | $331M | $141M | · | · | |
| PP&E (Net) | $13M | $10M | · | · | |
| Other Non-current Assets | $3M | $2M | · | · | |
| Total Assets | $391M | $186M | · | · | |
| Accounts Payable | $14M | $6M | · | · | |
| Current Liabilities | $28M | $24M | · | · | |
| Capital Leases | $39M | $29M | · | · | |
| Other Non-current Liabilities | $1M | $1M | · | · | |
| Total Liabilities | $78M | $130M | · | · | |
| Common Stock | $7.0K | $1.0K | · | · | |
| Paid-in Capital | $516M | $12M | · | · | |
| Retained Earnings | $-203M | $-190M | · | · | |
| AOCI | $-139.0K | $-80.0K | · | · | |
| Stockholders' Equity | $313M | $-178M | · | · | |
| Liabilities + Equity | $391M | $186M | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| D&A | $1M | $1M | $919.0K | $888.0K | |
| Stock-based Comp | $3M | $1M | $680.0K | $619.0K | |
| Operating Cash Flow | $-11M | $-20M | $-12M | $-13M | |
| CapEx | $4M | $600.0K | $753.0K | $554.0K | |
| Investing Cash Flow | $-121M | $-778.0K | $18M | $17M | |
| Financing Cash Flow | $202M | $56M | $164.0K | $243.0K | |
| Net Change in Cash | $70M | $35M | $7M | $4M | |
| Free Cash Flow | · | $-21M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Gross Margin | 60.2% | 55.5% | · | · | |
| Operating Margin | -46.0% | -47.4% | · | · | |
| Net Margin | -44.9% | -81.9% | · | · | |
| Pretax Margin | -45.2% | -80.1% | · | · | |
| EBITDA Margin | -46.0% | -47.4% | · | · | |
| ROA | -6.8% | -22.9% | · | · | |
| ROE | -8.4% | 23.9% | · | · | |
| ROIC | -4.3% | 7.1% | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | 11.9 | 5.9 | · | · | |
| Quick Ratio | 9.7 | 3.5 | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | · | · | |
| Inventory Turnover | 0.5 | 0.6 | · | · | |
| Receivables Turnover | 2.9 | 2.7 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Revenue / Share | $0.50 | $2.12 | · | · | |
| Cash Flow / Share | · | $-1.66 | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Sands Capital Life Sciences Pulse Fund II, L.P., Sands Capital Alternatives, LLC, SANDS FRANK M. ×2 filings | July 7, 2026 | 6.10% | Amendment | Passive investment | SEC |
| Illumina Innovation Fund II GP, L.L.C., Illumina Innovation Fund II, L.P., Illumina Innovation Fund III GP, L.L.C., Illumina Innovation Fund III, L.P., Nicholas Naclerio | April 23, 2026 | 9.60% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 9 insiders · 5 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Yuling Luo | Chief Executive Officer | April 20, 2026 J | 1,224,152 | 0 | 0 | $0 |
| Justin J. Mcanear | Chief Financial Officer | April 20, 2026 J | 37,220 | 0 | 0 | $0 |
| Timothy Ogden White | President | April 20, 2026 J | 491,803 | 0 | 0 | $0 |
| Shiping Chen | Chief Operating Officer | April 20, 2026 J | 760,105 | 0 | 0 | $0 |
| John L. Brottem | General Counsel | Sept. 14, 2026 A | 29,000 | 0 | 0 | $0 |
| Robert P Ragusa | Director | Sept. 1, 2026 A | 5,686 | 0 | 0 | $0 |
| Rebecca Chambers | Director | April 20, 2026 J | · | 0 | 0 | $0 |
| Nicholas Naclerio | Director | April 20, 2026 C | 5,686 | 1 | 0 | $3,999,998 |
| Frank Witney | Director | April 20, 2026 J | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 10 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWO · iShares Trust | 0.02% | 85,986 SH | Sept. 11, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 337,072 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 76,481 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 3,607 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 9,862 SH | Aug. 19, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 136,470 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 320,260 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,135 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 40,228 SH | Sept. 11, 2026 | Daily |
| ISCB · iShares Trust | · | 625 SH | Sept. 11, 2026 | Daily |
ALMR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 11 analysts
BUY
Median target
$34.00
-1.0%
4 36.4%
Strong Buy
5 45.5%
Buy
2 18.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-09-30Mean target $35.40 +3.0%
Now
Current price $34.36
Low$31.00
Mean$35.40
High$45.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ALMR | · | · | · | · | · | · |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| BIO | · | · | · | · | · | · |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | · |
| MRVI | · | -3.6 | -28.3% | -70.4% | -48.6% | 18.3% |
| FTRE | $1.61B | -1.6 | 1.0% | -36.2% | -171.1% | · |
| BLFS | · | -241.8 | 28.9% | · | · | · |
| PSNL | $816M | -8.7 | -17.7% | -116.7% | -36.0% | · |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026